Home

I doubt it Hornet Wear out mirna marker of tace rfa disaster Insightful Manifestation

Cureus | Hepatocellular Carcinoma in 2021: An Exhaustive Update | Article
Cureus | Hepatocellular Carcinoma in 2021: An Exhaustive Update | Article

Barcelona Clinic Liver Cancer Staging System and treatment allocation.... |  Download Scientific Diagram
Barcelona Clinic Liver Cancer Staging System and treatment allocation.... | Download Scientific Diagram

Recent perspectives on therapeutic significance of microRNAs in  hepatocellular carcinoma - ScienceDirect
Recent perspectives on therapeutic significance of microRNAs in hepatocellular carcinoma - ScienceDirect

JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular  Carcinoma: Why, When, How?
JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate  hepatocellular carcinoma progression by regulating cyclin-dependent kinase  1 expression | Cancer Cell International | Full Text
The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by regulating cyclin-dependent kinase 1 expression | Cancer Cell International | Full Text

PDF) MicroRNAs Related to TACE Treatment Response: A Review of the  Literature from a Radiological Point of View
PDF) MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View

Cancers | Free Full-Text | Surgical Resection plus Intraoperative Radiofrequency  Ablation versus Chemoembolization for the Treatment of Intermediate-Stage  (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A  Propensity Score-Matched Analysis
Cancers | Free Full-Text | Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis

Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in  patients with hepatocellular carcinoma. An intention-to-treat analysis -  ScienceDirect
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis - ScienceDirect

Biomedicines | Free Full-Text | Circulating MicroRNA-21 and MicroRNA-122 as  Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with  Transarterial Chemoembolization
Biomedicines | Free Full-Text | Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency  ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library
Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library

The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular  Carcinoma | IntechOpen
The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular Carcinoma | IntechOpen

Circulating tumor cells as a prognostic biomarker in patients with  hepatocellular carcinoma | Scientific Reports
Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma | Scientific Reports

Cancers | Free Full-Text | Current State of Liver-Directed Therapies and  Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma  (HCC)
Cancers | Free Full-Text | Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)

The Role of MicroRNAs in Hepatocellular Carcinoma
The Role of MicroRNAs in Hepatocellular Carcinoma

Cancers | Free Full-Text | Clinical Usefulness of Surgical Resection  Including the Complementary Use of Radiofrequency Ablation for  Intermediate-Stage Hepatocellular Carcinoma
Cancers | Free Full-Text | Clinical Usefulness of Surgical Resection Including the Complementary Use of Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

Frontiers | Clinical Applications of Liquid Biopsy in Hepatocellular  Carcinoma
Frontiers | Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma

Targeted therapy for hepatocellular carcinoma | Signal Transduction and  Targeted Therapy
Targeted therapy for hepatocellular carcinoma | Signal Transduction and Targeted Therapy

JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular  Carcinoma: Why, When, How?
JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and  diagnostics - ScienceDirect
Hepatocellular carcinoma and microRNA: New perspectives on therapeutics and diagnostics - ScienceDirect

Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in  transarterial chemoembolization‑treated hepatocellular carcinoma patients
Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients

Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency  ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library
Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation - Ikemoto - 2017 - Hepatology Research - Wiley Online Library

PDF) The clinical significance of microRNA-122 in predicting the prognosis  of patients with hepatocellular carcinoma: A meta-analysis validated by the  Cancer Genome Atlas dataset
PDF) The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset

Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in  transarterial chemoembolization‑treated hepatocellular carcinoma patients
Serum exosomal microRNA‑122 and microRNA‑21 as predictive biomarkers in transarterial chemoembolization‑treated hepatocellular carcinoma patients